Wells Fargo analyst Stephen Baxter lowered the firm’s price target on CVS Health (CVS) to $60 from $61 and keeps an Equal Weight rating on the shares. Following the bulk of earnings, the firm is updating models and detailed earnings bridges for each large cap MCO. Wells is not incorporating any election-related changes to its valuation framework at this time.
Don't Miss Our Christmas Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CVS: